Clinical studies recruiting near Bielefeld

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Evangelisches Krankenhaus Bielefeld - Johannesstift · Eli Lilly and Company · NCT07218380 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6386 · Galderma R&D · NCT06988605 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Onkologische Schwerpunktpraxis Bielefeld · AGO Study Group · NCT05009082 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Evangelisches Krankenhaus Bielefeld · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Gesellschaft für Epilepsieforschung e.V. · Longboard Pharmaceuticals · NCT06660394 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Evangelisches Krankenhaus Bielefeld · Goethe University · NCT02872987 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · Klinikum Bielefeld Rosenhohe /ID# 283715 · AbbVie · NCT06712628 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Ad
Phase 2 · Klinikum Bielefeld · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07176312 Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
Phase 2/Phase 3 · Klinikum Bielefeld - Onkologie, Hämatologie, Paliativmedizin · University Hopsital Schleswig Holstein Campus Lübeck · NCT05665140 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
Phase 2 · Klinikum Bielefeld · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07387198 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Evangelisches Klinikum Bethel · University Hospital Freiburg · NCT06830421 The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · Universitätsklinik für Psychiatrie und Psychotherapie Bielef · Dr. Inge Winter · NCT05958875 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 · Onkologische Schwerpunktpraxis Bielefeld · University of Heidelberg Medical Center · NCT06216158 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Evangelisches Krankenhaus Bielefeld GmbH, Klinik für Kinder- · University Hospital Muenster · NCT04043494 Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NS
Phase 2 · Evangelical Hospital Bethel, Clinic for Internal Medicine, H · CatalYm GmbH · NCT07098988 Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
Phase N/A · Evangelisches Klinikum Bethel (EvKB) · W.L.Gore & Associates · NCT05846581 Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic N
Phase 2 · Evangelical Hospital Bethel, Clinic for Internal Medicine, H · CatalYm GmbH · NCT07246863 German-funded Laparoscopic Approach to Cervical Cancer
NA · Hospital Bielefeld - Center, Department of Gynecology · Hannover Medical School · NCT06489795 Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
Phase 2 · Onkologische Schwerpunktpraxis Bielefeld · Christian Buske · NCT05099471 Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer
Phase 2 · Onkologische Schwerpunktpraxis Bielefeld · GBG Forschungs GmbH · NCT05306041 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Phase 3 · Evangelisches Klinikum Bethel · Mats Heyman · NCT04307576 Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NA · Klinikum Bielefeld gem. GmbH, Klinik für Kardiologie und Int · Leipzig Heart Science gGmbH · NCT05786131 The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Us
Phase 3 · Universitätsklinik für Psychiatrie und Psychotherapie Bielef · Dr. Inge Winter · NCT05973851 Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Phase 2 · Evangelisches Klinikum Bethel, Children's Hospital · German Society for Pediatric Oncology and Hematology GPOH gG · NCT06019130

Look up another city

Look up another condition